| scholarly article | Q13442814 |
| P50 | author | Monina Klevens | Q91805742 |
| Geraldine McQuillan | Q114424401 | ||
| Ruth Jiles | Q115103255 | ||
| Maxine M Denniston | Q115103258 | ||
| P2860 | cites work | Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention | Q28286743 |
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 | Q29620136 | ||
| Natural history of chronic hepatitis C | Q29620673 | ||
| Is sexual contact a major mode of hepatitis C virus transmission? | Q34126319 | ||
| Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force | Q35692299 | ||
| A validation of self-reported substance use with biochemical testing among patients presenting to the emergency department seeking treatment for backache, headache, and toothache | Q37130293 | ||
| Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas | Q37401981 | ||
| Public health impact of antiviral therapy for hepatitis C in the United States | Q39939298 | ||
| Identification and management of hepatitis C patients in primary care clinics | Q43049186 | ||
| The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance | Q44280003 | ||
| Identification of Patients with Hepatitis C Virus Infection in New Haven County Primary Care Practices | Q45724552 | ||
| Utilization and antiviral therapy in patients with chronic hepatitis C: analysis of ambulatory care visits in the US. | Q46076105 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| P304 | page(s) | 1652-1661 | |
| P577 | publication date | 2012-04-10 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008 | |
| P478 | volume | 55 |
| Q94570297 | A Big Step Forward in Hepatitis C Screening |
| Q59353097 | A Multi-Fidelity Rollout Algorithm for Dynamic Resource Allocation in Population Disease Management |
| Q57825993 | A Population-Based Surveillance Study on the Epidemiology of Hepatitis C in Estonia |
| Q51797246 | A Public Health Approach to Hepatitis C in an Urban Setting. |
| Q87061121 | A brighter future in the fight against hepatitis |
| Q40264791 | A comparative study of patients' knowledge about hepatitis C in the United States and in urban and rural China |
| Q58693999 | A liver health hui: hepatitis C knowledge and associated risk factors in New Zealand gang members and their families |
| Q36161813 | A multidimensional education program at substance dependence treatment centers improves patient knowledge and hepatitis C care |
| Q39047531 | A systematic model improves hepatitis C virus birth cohort screening in hospital-based primary care |
| Q38928083 | A systematic review and meta-analysis of HCV clearance |
| Q92180464 | Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study |
| Q33364626 | Age, hepatitis C virus infection, and the risk of cancer: Unlocking a complex puzzle of interactions |
| Q52614832 | An Education and Field Experience Program to Increase Detection of Human Immunodeficiency Virus and Hepatitis C Virus. |
| Q30746254 | Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer |
| Q52597014 | Approaches for simplified HCV diagnostic algorithms. |
| Q55415730 | Assessing the level of knowledge and available sources of information about hepatitis C infection among HCV-infected Egyptians. |
| Q43751876 | Association of tattooing and hepatitis C virus infection: a multicenter case-control study. |
| Q90216356 | Awareness and knowledge of hepatitis C among health care providers and the public: A scoping review |
| Q40503644 | Awareness of Hepatitis C Virus Seropositivity and Chronic Infection in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). |
| Q37170594 | Building a Community - Academic Partnership to Enhance Hepatitis C Virus Screening |
| Q41703119 | Changes in characteristics of hepatitis C patients seen in a liver centre in the United States during the last decade |
| Q37543670 | Characterizing Failure to Establish Hepatitis C Care of Baby Boomers Diagnosed in the Emergency Department |
| Q38797618 | Chronic hepatitis B and C infection in the United States: a review of current guidelines, disease burden and cost effectiveness of screening |
| Q90733713 | Chronic hepatitis C infection: how much are physicians aware of? |
| Q36035889 | Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010 |
| Q40054265 | Cohort Contributions to Race- and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA. |
| Q90353204 | Comorbid hepatitis C does not modulate prevalence or severity of diabetic retinopathy |
| Q92480921 | Comparing drug safety of hepatitis C therapies using post-market data |
| Q42198665 | Comparison of hepatitis C virus testing strategies: birth cohort versus elevated alanine aminotransferase levels. |
| Q35543361 | Comparison of risk-based hepatitis C screening and the true seroprevalence in an urban prison system |
| Q38917876 | Considerations on bringing warehoused HCV patients into active care following interferon-free, direct-acting antiviral drug approval |
| Q40330235 | Continuum of Care for Hepatitis C Virus Among Patients Diagnosed in the Emergency Department Setting |
| Q37373215 | Correlates of disease-specific knowledge among patients with chronic hepatitis B or hepatitis C infection in India |
| Q39043108 | Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study |
| Q34735072 | Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs |
| Q47557121 | Detecting Hepatitis B and C by Combined Public Health and Primary Care Birth Cohort Testing. |
| Q87870147 | Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study |
| Q33572715 | Development and validation of a clinical scoring system for predicting risk of HCC in asymptomatic individuals seropositive for anti-HCV antibodies |
| Q57212438 | Development of a Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect Hepatitis B Surface Antigen (HBsAg), Antibody to HBsAg, and Antibody to Hepatitis C |
| Q90026182 | Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City |
| Q36484185 | Dual-Routine HCV/HIV Testing: Seroprevalence and Linkage to Care in Four Community Health Centers in Philadelphia, Pennsylvania |
| Q34296321 | Duplicate hepatitis C antibody testing in New York City, 2006-2010. |
| Q37075726 | Epidemiology of Infectious Disease-Related Death After Release from Prison, Washington State, United States, and Queensland, Australia: A Cohort Study |
| Q55270239 | Estimated prevalence of Hepatitis C Virus infection in Canada, 2011. |
| Q86945740 | Estimating HCV prevalence at the state level: a call to increase and strengthen current surveillance systems |
| Q58606990 | Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016 |
| Q36133794 | Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era |
| Q53070128 | Estimating the Number of Patients Infected With Chronic HCV in the United States Who Meet Highest or High-Priority Treatment Criteria. |
| Q59358303 | Estimating the prevalence of chronic hepatitis C virus infection in New York City, 2015 |
| Q30622845 | Estimating the prevalence of hepatitis C infection in New York City using surveillance data |
| Q41744442 | Estimating the treatment cascade of chronic hepatitis B and C in Greece using a telephone survey. |
| Q35147007 | Estimating the true prevalence of hepatitis C in rhode island |
| Q35861153 | FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53. |
| Q40076192 | Failure to Test and Identify Perinatally Infected Children Born to Hepatitis C Virus-Infected Women. |
| Q64078101 | Family Counseling for Hepatitis B and Hepatitis C |
| Q39502664 | Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort Study |
| Q92969904 | Geospatial epidemiology of hepatitis C infection in Egypt 2017 by governorate |
| Q37077112 | Global control of hepatitis C: where challenge meets opportunity |
| Q59350900 | HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design |
| Q31012317 | HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape |
| Q42050428 | HCV Health Policy Developments in Response to the National Viral Hepatitis Action Plan: A Brief Update |
| Q38710078 | Healthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs |
| Q89623932 | Hepatitis B and C screening needs among different ethnic groups: A population-based study in Amsterdam, the Netherlands |
| Q92486069 | Hepatitis C Antibody Positive, RNA Negative |
| Q40528873 | Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals |
| Q91801771 | Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection |
| Q33595820 | Hepatitis C Point-of-Care Screening in Retail Pharmacies in the United States |
| Q59357435 | Hepatitis C Screening in Commercially Insured U.S. Birth-cohort Patients: Factors Associated with Testing and Effect of an EMR-based Screening Alert |
| Q90302778 | Hepatitis C Virus Antibody Screening in a Cohort of Pregnant Women: Identifying Seroprevalence and Risk Factors |
| Q90095540 | Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013-2016 |
| Q36167835 | Hepatitis C Virus Screening and Emergency Department Length of Stay. |
| Q37578288 | Hepatitis C Virus: A Review of Treatment Guidelines, Cost-effectiveness, and Access to Therapy |
| Q57445746 | Hepatitis C Within a Single Health System: Progression Along the Cascade to Cure Is Higher for Those With Substance Misuse When Linked to a Clinic With Embedded Support Services |
| Q33578932 | Hepatitis C among blood donors: cascade of care and predictors of loss to follow-up. |
| Q61448697 | Hepatitis C elimination: challenges with under-diagnosis and under-treatment |
| Q34044333 | Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus |
| Q33706886 | Hepatitis C in Argentina: epidemiology and treatment |
| Q64085681 | Hepatitis C in pregnant American Indian and Alaska native women; 2003-2015 |
| Q42992102 | Hepatitis C in the United States |
| Q34008754 | Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy |
| Q38403156 | Hepatitis C virus infection and the risk of cancer among elderly US adults: A registry-based case-control study. |
| Q38371502 | Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study |
| Q36562909 | Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance |
| Q35501190 | Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade |
| Q38166700 | Hepatitis C virus: an overview for dental health care providers |
| Q36306768 | Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals |
| Q42212155 | Hepatitis C: Treatment triumphs |
| Q40554744 | Hepatocellular Carcinoma and Viral Hepatitis in New York City |
| Q42228465 | Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach. |
| Q34280145 | Historical trends and projected hospital admissions for chronic hepatitis C infection in Canada: a birth cohort analysis |
| Q36009124 | Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan |
| Q40966047 | Identification and Linkage to Care of HCV-Infected Persons in Five Health Centers - Philadelphia, Pennsylvania, 2012-2014. |
| Q58723499 | Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study |
| Q36594965 | Immunity and hepatitis C: a review |
| Q33745336 | Impact of an Electronic Medical Record-Based System to Promote Human Immunodeficiency Virus/Hepatitis C Virus Screening in Public Hospital Primary Care Clinics |
| Q39238840 | Impact of birth cohort screening for hepatitis C. |
| Q40047408 | Improving Hepatitis C Identification: Technology Alone Is Not the Answer. |
| Q93068104 | Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013 |
| Q56654945 | Increasing hepatitis C screening in a large integrated health system: science and policy in concert |
| Q37052096 | Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection |
| Q51872330 | Indications for testing among reported cases of HCV infection from enhanced hepatitis surveillance sites in the United States, 2004-2010. |
| Q52312138 | Insights on the Russian HCV Care Cascade: Minimal HCV Treatment for HIV/HCV Co-infected PWID in St. Petersburg. |
| Q30245478 | Interventions to optimise the care continuum for chronic viral hepatitis: a systematic review and meta-analyses. |
| Q39394760 | Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis C. |
| Q56342192 | Knowledge of Hepatitis C Risk Factors is Lower in High Incidence Regions |
| Q41256468 | Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C follow-up study |
| Q59352206 | Limited Coverage of Hepatitis C Virus Testing in the United States, 2013-2017 |
| Q33654457 | Living with Hepatitis C Virus: A Systematic Review and Narrative Synthesis of Qualitative Literature. |
| Q42276702 | Locations and reasons for initial testing for hepatitis C infection--chronic hepatitis cohort study, United States, 2006-2010. |
| Q33853664 | Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection. |
| Q27002381 | Modeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infections |
| Q38738857 | Modulation of HCV replication and translation by ErbB3 binding protein1 isoforms |
| Q56891090 | Monitoring the hepatitis C care cascade using administrative claims data |
| Q42237381 | Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010. |
| Q51846242 | Mortality caused by chronic liver disease among American Indians and Alaska Natives in the United States, 1999-2009. |
| Q35818327 | Most Patients of Hepatitis C Virus Infection in India Present Late for Interferon-Based Antiviral Treatment: An Epidemiological Study of 777 Patients from a North Indian Tertiary Care Center. |
| Q37500066 | Multicountry burden of chronic hepatitis C viral infection among those aware of their diagnosis: a patient survey |
| Q34354269 | National estimates of healthcare utilization by individuals with hepatitis C virus infection in the United States |
| Q37015805 | New perspectives for preventing hepatitis C virus liver graft infection |
| Q37150660 | New triple therapy for chronic hepatitis C: real life clinical experience in a community setting |
| Q52564579 | Newly Diagnosed Hepatitis C in the US Commercially Insured Population Before and After the 2012 Implementation of Expanded Screening Guidelines. |
| Q36646287 | On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial |
| Q59353323 | Optimal Information Collection Policies in a Markov Decision Process Framework |
| Q38827613 | Organ system view of the hepatic innate immunity in HCV infection |
| Q47999149 | Paritaprevir/ritonavir/ombitasvir+dasabuvir plus ribavirin therapy and inhibition of the anticoagulant effect of warfarin: a case report. |
| Q94592980 | Patients Lost after Anti-HCV-Positive Finding in a Tertiary Care University Hospital: Increased Awareness and Action is Necessary to Eradicate HCV |
| Q40809349 | Performance of rapid diagnostic tests for the detection of antibodies to hepatitis C virus in whole blood collected on dried blood spots |
| Q48506117 | Population level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States |
| Q40049914 | Population-level intervention and information collection in dynamic healthcare policy. |
| Q37204909 | Predictors of Inpatient Mortality and Resource Utilization for the Elderly Patients With Chronic Hepatitis C (CH-C) in the United States |
| Q39908742 | Presence of hepatitis C (HCV) infection in Baby Boomers with Medicare is independently associated with mortality and resource utilisation |
| Q38323723 | Prevalence and treatment of chronic hepatitis C virus infection in the US Department of Veterans Affairs |
| Q64118358 | Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices |
| Q51852531 | Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, United States, 1999-2008. |
| Q37573484 | Primary Care Providers Knowledge, Attitude and Practices Related to Hepatitis C Screening and Treatment in the Oral Direct Acting Antiviral Agents Era. |
| Q36813466 | Public health clinic-based hepatitis C testing and linkage to care in Baltimore. |
| Q42235045 | Racial disparities in the proportion of current, unresolved hepatitis C virus infections in the United States, 2003-2010. |
| Q53624781 | Restrictions of Hepatitis C Treatment for Substance-Using Medicaid Patients: Cost Versus Ethics. |
| Q35752660 | Results from a Geographically Focused, Community-Based HCV Screening, Linkage-to-Care and Patient Navigation Program |
| Q90560707 | Retracted: Electronic Clinical Decision Support Intervention to Increase Hepatitis C Screening and Linkage to Care Among Baby Boomers in Urban Safety Net Health Systems |
| Q99405804 | Screening Adult Children of Hepatitis C-Infected Baby Boomers: Barriers to Testing and Prevalence Estimates |
| Q64099261 | Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study |
| Q36579211 | Senior Center-Based Hepatitis C Screening in Baltimore |
| Q28545237 | Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testing |
| Q36609564 | Seroprevalence of Hepatitis B and C Infections among Healthy Volunteer Blood Donors in the Central California Valley |
| Q28079102 | State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization |
| Q40779777 | Streamlining Screening to Treatment: The Hepatitis C Cascade of Care at Kaiser Permanente Mid-Atlantic States |
| Q40146605 | Sub-optimal Testing and Awareness of HCV and HBV Among High Risk Individuals at an Underserved Safety-Net Hospital. |
| Q92916687 | Temporal trends in liver cancer mortality by educational attainment in the United States, 2000-2015 |
| Q46490867 | The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing |
| Q47115868 | The continuum of hepatitis C care for criminal justice involved adults in the DAA era: a retrospective cohort study demonstrating limited treatment uptake and inconsistent linkage to community-based care |
| Q40231197 | The continuum of hepatitis C testing and care. |
| Q64094653 | The disconnect in hepatitis screening: participation rates, awareness of infection status, and treatment-seeking behavior |
| Q33632459 | The hepatitis C cascade of care: identifying priorities to improve clinical outcomes |
| Q38099825 | The hidden epidemic of hepatitis C virus infection in the United States: occult transmission and burden of disease |
| Q30250096 | The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma |
| Q39418450 | The oncologic burden of hepatitis C virus infection: A clinical perspective. |
| Q33837518 | The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis |
| Q35593482 | The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014 |
| Q38996459 | The value of cure associated with treating treatment-naïve chronic hepatitis C genotype 1: Are the new all-oral regimens good value to society? |
| Q38163155 | Treatment as prevention and cure towards global eradication of hepatitis C virus |
| Q38177972 | Treatment of chronic hepatitis C virus infection in the United States: some remaining obstacles |
| Q30235034 | Treatment optimization for HIV/HCV co-infected patients |
| Q40039247 | Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health |
| Q38685582 | Universal screening for chronic hepatitis C virus |
| Q40219302 | Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department. |
| Q38791337 | What's Important to the Patient? Informational Needs of Patients Making Decisions About Hepatitis C Treatment |
Search more.